Atlas Trials

Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

Clinical trial NCT04871945 · COMPLETED

Trial details

NCT number
NCT04871945
Sponsor
Hanyang University Seoul Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Covid19Vaccine ReactionHemolysisEnd-stage Renal Disease
Start date
2021-04-20
Primary completion
2021-09-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.